En español
NIDA

Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

"No Smoking" sign

Nicotine dependence is common among drug and alcohol dependent patients. This multi-site trial evaluated the effectiveness of smoking-cessation treatment with transdermal nicotine patch replacement (SC) as an adjunct to treatment-as-usual for illicit substance abuse (TAU). Cigarette smokers from five methadone-maintenance clinics and two drug and alcohol dependence treatment programs were randomly assigned to receive either SC as an adjunct to usual care or TAU. SC consisted of 1 week of group counseling before the target quit date and 8 weeks of group counseling plus transdermal nicotine patch replacement treatment after the target quit date.

CTN Protocol ID: 
CTN-0009
DSMB ID: 
NIDA-CTN-0009
Enrollment Status: 
Completed
ClinicalTrials.gov ID: 
Primary Outcomes Article: 

Reid, M., et al. (2008).  Smoking cessation treatment in community-based substance abuse rehabilitation programs.  Journal of Substance Abuse Treatment 35(1):68-77.
http://www.ncbi.nlm.nih.gov/pubmed/17951021

Principal Investigator(s)
John Rotrosen, M.D.
Professor
NYU School of Medicine
Department of Psychiatry
423 East 23rd Street, 17W
New York, NY 10010
john.rotrosen@nyumc.org

Available Brochures

Get this Publication

    Blending Initiative

    blending logo

    Formed with SAMHSA to reduce the gap between research results and treatment.